NEWS COMMENTARY

Researchers at Swiss Federal Institute of Technology Lausanne developing digital biomarker for COVID-19 based on cough sounds

Published:
April 23, 2020
Coverage:
Digital Transformation More...
Activities:
Project
Very important

The Embedded Systems Laboratory is developing a digital biomarker to be used for the diagnosis of COVID-19 based on cough sounds collected from a smartphone speaker. Cough sounds have long been used in diagnosing respiratory diseases, and more recently, the use of computer vision coupled with sensors in mobile devices has allowed for the development of digital endpoints for clinical trials, such as by the company HealthMode. Digital biomarkers are an emerging technology that allows for earlier and more personalized diagnostics, and clients should be looking invest in this technology as an accompaniment to current digital health offerings like wearables, digital therapeutics, and telehealth services.

For the original news article, click here .


Further Reading

Smart ring company Oura seeks digital biomarkers for COVID-19 in research study with University of California, San Francisco

News Commentary | March 24, 2020

This research study to identify digital biomarkers comes on the heels of other studies based on smartphones and other wearables for early detection of other medical conditions, such as dementia and depression – as well as, in a notable study with Fitbit, the flu. This research is not only important ... To read more, click here.

New voice-based app helps diagnose mental health disorders with voice analysis

News Commentary | September 09, 2020

Ellipsis Health is now offering an app that allows healthcare providers to remotely monitor for signs of mental health concerns like depression and anxiety. Digital biomarkers have been steadily gaining traction in the healthcare field, typically as tools for clinical trials and in research. This ... Not part of subscription

In collaboration with Apple, Biogen announces study collecting digital biomarkers for cognitive decline

News Commentary | February 17, 2021

This pilot study announcement lacks details on the feasibility of developing these digital biomarkers and raises issues about how the study will be conducted. There are major privacy concerns associated with sending detailed reports on device usage, and it remains to be seen how Apple will ... Not part of subscription